Shailyamanyu Singh v. State of Maharashtra
- Citation
- 2025 INSC 995; [2025] 7 S.C.R. 2085
- Court
- Supreme Court of India
- Bench
- 2 Judges: Justice Vikram Nath, Justice Sandeep Mehta
- Decided
- 22 Jul 2025
- Case number
- CRIMINAL APPEAL No. 3104/2025
- Sections
- 34, 34(2), 482, 18B, 28A, 18, 22(1), 27, 34(1)
Not a certified copy. Text extracted from the judgment PDF published by the Supreme Court of India. Verify against the certified copy before relying on it. Source: Supreme Court of India, via the Indian Supreme Court Judgments dataset by Dattam Labs (CC-BY-4.0). Retrieved 17 Nov 2026, 12:19 am. Original source ↗
Preview: first 50% of the document.
[2025] 7 S.C.R. 2085 : 2025 INSC 995 Shailyamanyu Singh v.
State of Maharashtra (Criminal Appeal No. 3104 of 2025)
22 July 2025 [Vikram Nath and Sandeep Mehta,* JJ.] Issue for Consideration Issue arose whether the appellant, being a non-executive Director of the company, can be held vicariously liable and prosecuted for the alleged offences committed by the company.
Headnotes† Drugs & Cosmetics Act, 1940 – s.34 – Offences by companies – Vicarious liability of a Director of the company – Appellant summoned as an accused in the complaint case in capacity of the Director of the company which was distributor of the drug – Appellant challenged the order passed by the Magistrate taking cognizance of the offences under the various provisions of the 1943 Act and issuing process – High Court dismissed the petition – Sustainability:
Held: Prosecution of the appellant on the anvil of vicarious liability simply being a Director of the company is absolutely unjustified and tantamounts to a gross abuse of the process of law – It is clear from ss.34(1) and 34(2) that every person who is in-charge of the day-to-day affairs of the company and the Director or Directors would be liable to face prosecution under the Act – There definitely has to exist a prima facie allegation in the complaint which can satisfy the Court regarding the consent, connivance or attributable neglect on the part of the Director who is sought to be prosecuted by taking recourse to the concept of vicarious liability as provided u/s.34(2) – Complaint totally silent on this vital aspect – Finding of the High Court that it could be inferred from the averments made in the complaint that the appellant had distributed the drugs in favour of the enterprise which did not possess a valid license under the Act, is erroneous – Allegation of distributing the drugs to an enterprise without a license is omnibus against both the appellant * Author 2086 [2025] 7 S.C.R.Supreme Court Reports as well as against the company and thus, something more than a bald allegation is required which satisfies the necessary ingredients of the offences under the Act, to make the appellant vicariously liable for the acts and omissions of the company – Neither of the Director, Manager or any other officer in-charge of the company has been impleaded in the complaint – Complaint totally devoid of averments regarding any inquiry into the role of the Directors of the company or the person/s responsible for the conduct of the day-to-day business of the company – Thus, there being no such averment or material against the appellant, the order summoning him is ex facie unjustified and uncalled for – Judgment and order by the High Court unsustainable in the eyes of law and set aside – Summoning order and all proceedings sought to be taken against the appellant in the complaint quashed. [Paras 21-31] Case Law Cited Lalankumar Singh & Ors. v. State of Maharashtra [2022] 14 SCR 573 : (2022) SCC OnLine SC 1383; Sunita Palita & Ors. v. Panchmani Stone Quarry [2022] 14 SCR 458 : (2022) 10 SCC 152; Siby Thomas v. Somay Ceramics Ltd. [2023] 13 SCR 821 : (2024) 1 SCC 348; Dayle De’Souza v. Union of India (2021) 20 SCC 135; National Small Industries Corporation Limited v. Harmeet Singh Paintal [2010] 2 SCR 805 : (2010) 3 SCC 330 – referred to. List of Acts Drugs & Cosmetics Act, 1940; Code of Criminal Procedure, 1973. List of Keywords Non-executive Director of the company; Vicarious liability; Offences committed by the company; Vicarious liability of a Director of the company; Summoning as an accused; Distributor of the drug; Cognizance; Day-to-day affairs of the company; Specific averments; Valid license; Abuse of the process of law.
Case Arising From CRIMINAL APPELLATE JURISDICTION: Criminal Appeal No.
3104 of 2025 From the Judgment and Order dated 12.04.2023 of the High Court of Judicature at Bombay in CRLAP No. 1422 of 2019 [2025] 7 S.C.R. 2087Shailyamanyu Singh v. State of Maharashtra Appearances for Parties Advs. for the Appellant:
Sidharth Luthra, Sr. Adv., Dheeraj Nair, Kumar Kislay, Ms. Vishrutyi Sahni, Ms. Ridhima Sharma.
Advs. for the Respondent:
Ms. Rukhmini Bobde, Siddharth Dharmadhikari, Aaditya Aniruddha Pande, Shrirang B. Varma, Ms. Soumya Priyadarshinee, Vinayak Aren, Amlaan Kumar, Jatin Dhamija, Naveen Kumar Bhardwaj. Judgment / Order of the Supreme Court Judgment Mehta, J.
1. Heard.
2. Leave granted.
3. The instant appeal is preferred against the judgment and order dated 12 th April, 2023 passed by the High Court of Judicature at Bombay 1 whereby the Criminal Application No. 1422 of 2019 filed by the appellant under Section 482 of Code of Criminal Procedure, 1973 2 came to be rejected.
4. By way of the said petition filed under Section 482 CrPC, the appellant had challenged the order dated 3 rd December, 2016 passed by the Metropolitan Magistrate 15th Court, Mazgaon, Mumbai in Criminal Case No. 1500201/SW/2016, taking cognizance of the offences under Section 18B punishable under Section 28A, Section 18(a)(vi) and Section 22(1)(cca) punishable under Section 27(d) of the Drugs & Cosmetics Act, 19403 and issuing process against numerous accused including the appellant.
Brief Facts: -
5. The appellant (accused No.6) was summoned as an accused in the complaint case in capacity of the Director of Procter and Gamble 1 Hereinafter, being referred to as the ‘High Court’.
2 For short “CrPC”.
3 Hereinafter being referred to as the ‘D&C Act’.
2088 [2025] 7 S.C.R.Supreme Court Reports Hygiene and Healthcare Limited4 (accused No.7), which was the distributor of the drug in question, i.e., Vicks Multi Pain Relief Gel. The said drug was manufactured by its licensed manufacturer, Akums Drugs and Pharmaceuticals Ltd. (accused No. 8). The expiry date of the drug was January, 2016. As per the Standard Operating Procedure (SOP) of P&G Ltd., drugs set to expire within the next six months were required to be destroyed. Accordingly, the company initiated the process of recalling and destroying the said batch of the subject drug in May 2015.
6. On 3 rd June, 2016, upon receiving information from the Vigilance Department, the Drug Inspector visited the premises of an enterprise namely, M/s Action Soap Center. The inspection revealed that a stock of the aforesaid drug of which expiry date had already lapsed, was illegally stored in the godown. On questioning the person-in-charge of M/s Action Soap Center, it came to light that the drug had been procured from P&G Ltd. Subsequently, on 7 th June, 2016 a notice was sent by the Drug Inspector to P&G Ltd. inquiring about the drugs seized from the premises of M/s Action Soap Center.
7. The inquiry notice dated 7 th June, 2016 was responded to vide letter dated 13th June, 2016, by Ms. Saumya Ranjan in the capacity of the competent person acting on behalf of P&G Ltd. explaining that the purchase and sale of the drug was being carried out under her supervision. Thereafter, two further show cause notices dated 15th June, 2016 and 17 th June 2016 were issued to P&G Ltd. seeking explanation for supply of drug to M/s Star Express, an enterprise which did not possess a valid license under the D&C Act.
8. The appellant in discharge of his duties as the legal officer of the company responded to these show cause notices and the queries raised therein by the Drug Inspector vide letter dated 5 th July, 2016. It was stated in the reply that the drugs in question were in the legal custody of the Clearing and Forwarding Agent (C&F) i.e. M/s. KD Supply Chains Solution Pvt. Ltd. and were forwarded to M/s Star Express by the said C&F Agent.
9. However, it is not necessary to delve into the above aspect of the matter, as the controversy in the present appeal is confined to the 4 Hereinafter, referred to as the ‘P&G Ltd. or Company’ [2025] 7 S.C.R. 2089Shailyamanyu Singh v. State of Maharashtra question as to whether the appellant, being a Non-Executive Director of the company, can be held vicariously liable and prosecuted for the alleged offences committed by the company.
10. Pursuant to the completion of the inquiry, the Drug Inspector proceeded to file a complaint in the Court of Metropolitan Magistrate, Mazgaon, Mumbai which came to be registered as Criminal Case No. 1500201/SW/2016. The array of the respondents in the aforesaid complaint is as below: - S. No. Name Description
1. Yusuf Khan Person-in-charge of M/s Action Soap Center
2. Rahis Gaman Khan Proprietor, M/s Action Soap Center
3. Girish Chamadia Director of M/s C.G.
Marketing Pvt. Ltd.
4. C.G. Marketing Pvt Ltd. -
5. Amol Sawant Asst. Logistic Executive, C.G. Marketing Pvt Ltd.
6. Shailyamanyu Singh Director of P&G Ltd.
7. Procter & Gamble Hygiene Ltd.
Company
8. Akums Drugs & Pharmaceutical Manufacturing Company
11. The averments set out in the complaint qua the appellant (accused No. 6) are as below: - “7. That the Accused No.6, is Mr. Shailyamanyu Singh - Director of M/s. Procter and Gamble Hygiene and Health Care Ltd., P & G Plaza, Cardinal Gracias Road, Chakala Andheri (E), Mumbai 400099 which is the manufacturing company which had manufactured the said drug at the manufacturing site at M/s. Akums Drugs & Pharmaceuticals Ltd., Plant V, Hardware under manufacturing no. 16/ UA/2010 dated 13.08.2010 and distributed the said drug to Accused No.5.”
2090 [2025] 7 S.C.R.Supreme Court Reports “31. That the investigation carried out by complainant, it is revealed as under – iv. That, Accused No.6 and 7 distributed drugs for the purpose of sale and distribution to M/s. Star Express, Navi Mumbai who is not holding any requisite license under Drugs and Cosmetics Act. 1940. Accused No.7 and 8 have not submitted properly relevant document for destruction of the said drug and not provided relevant documents of destruction and thereby contravened Section of 18(c) p/u Section 27(b)
(ii) and 18-B P/u 28 A of Drugs and Cosmetics Act, 1940.”
“36. That the Investigation carried out by complainant, it is revealed as under –
(4) That, Accused No.6 and 7 distributed drugs for the purpose of sale and distribution to M/s. Star Express, Navi Mumbai who is not holding any requisite license under Drugs and Cosmetics Act. 1940.”
(Emphasis supplied)
Continue reading
Sign in and become a member to continue reading this judgment and every other document in the library.
Members read the full text, download where permitted, and keep notes and bookmarks.